Form 4: Korro Bio Investor Scott Sandell Acquires Shares in Recent Transaction

Scott Sandell, a director of Korro Bio, acquired 17,857 shares of common stock at $56 per share on April 22, 2024, through a subscription agreement.

Summary

• On April 22, 2024, Scott Sandell, a director of Korro Bio, acquired 17,857 shares of common stock.
• The shares were purchased at a price of $56 per share.
• The transaction was made pursuant to a subscription agreement dated April 17, 2024.
• Following the transaction, Sandell indirectly owns 1,090,793 shares through NEA 17 GP, LLC, the sole general partner of NEA Partners 17, L.P., which is the sole general partner of New Enterprise Associates 17, L.P. ('NEA 17').
• Sandell disclaims beneficial ownership of the securities held by NEA 17 except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard transaction disclosure; the director's purchase is a mildly positive signal.

Positives

• A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.

Key Dates